NFL Biosciences SA (EPA:ALNFL)
France · Delayed Price · Currency is EUR 1.282
0.00 (0.00%)
At close: Jan 30, 2026
NFL Biosciences Market Cap
NFL Biosciences has a market cap or net worth of €16.25 million as of January 30, 2026. Its market cap has decreased by -11.72% in one year.
Market Cap
16.25M
Enterprise Value
14.17M
Revenue
164.00
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.28
Market Cap Chart
Since July 5, 2021, NFL Biosciences's market cap has decreased from 19.47M to 16.25M, a decrease of -16.57%. That is a compound annual growth rate of -3.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 16.25M | 8.83% |
| Dec 31, 2025 | 14.93M | -21.92% |
| Dec 31, 2024 | 19.12M | 63.78% |
| Dec 29, 2023 | 11.67M | 13.49% |
| Dec 30, 2022 | 10.29M | -18.13% |
| Dec 31, 2021 | 12.56M | -35.48% |
| Jul 5, 2021 | 19.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fermentalg | 41.13M |
| THX Pharma Société Anonyme | 34.49M |
| Nicox | 31.73M |
| Advicenne | 23.72M |
| genOway Société anonyme | 22.77M |
| Aelis Farma | 21.00M |
| Poxel | 17.95M |
| GenSight Biologics | 17.40M |